Dietary vitamin C may maintain healthy blood vessels in patients with inflammatory diseases.

A subpopulation of bone cancer cells may be responsible for driving clinically aggressive behavior, suggesting new treatment options.

Targeting the production of molecules that promote tumor blood vessel development offers a new path for treating lung cancer.

A metabolic enzyme plays a crucial role in vascular development and may be a good target for cancer therapies.

A newly identified factor regulates blood vessel growth in colorectal tumors and could be a promising target for cancer therapies.

Dysfunction of the endothelial cells that line blood vessels may contribute to delirium and coma in critically ill patients – and could be a target for therapy.

The protein TIP-1 appears to be a novel prognostic marker for glioblastoma and may be a good therapeutic target for disrupting tumor-driven blood vessel development.